Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Prostate Cancer
Interventions
DRUG

Androgen Deprivation Therapy (ADT) - Goserelin

"The patients under ADT and the patients who will receive the ADT during the study will be included in the trial.~* ADT will be applied for 24 months in total~* ADT must be given concurrently and adjuvant"

RADIATION

High-Dose-Rate Interstitial Brachytherapy (HDR BRT)

HDR BRT Procedure will be performed using transperineal catheter implantation under transrectal US-guidance performed under anesthesia, spinal or general with patient in high lithotomy position.)

RADIATION

radiotherapy

EBRT prostate + elective pelvis (Ultra-hypofractionated): 25 Gy in 5 Gy per fraction

Trial Locations (1)

4108

RECRUITING

German Oncology Center, Limassol

All Listed Sponsors
lead

German Oncology Center, Cyprus

OTHER